You searched for oncology

Interview 26 May 2021

Immuno-Oncology: From Science Fiction to the Mainstream

…getting more and more complicated in this field now because the largest part of biotech is oncology, and the largest part of oncology is immuno-oncology.” The quality of the science,…

May 26, 2021 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Nov 2022

Alkermes to separate oncology business

…the oncology business into an independent, publicly-traded company (Oncology Co.) as part of an ongoing review of strategic alternatives for the oncology business. Alkermes said it believes separation of the…

November 2, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 24 Feb 2020

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

With the success of CAR T-cell therapies and other innovative medicines in this area, immuno-oncology has become a buzzword in biotech, with more and more companies starting up in Europe…

February 24, 2020 - 12 minutesmins - By Larissa Warneck-Silvestrin

In Depth 6 Jul 2020

How Immuno-Oncology Contributes to the Fight Against Covid-19

…that previously had few options left. Fortunately, these advancements in immuno-oncology can be used in the fight against infectious diseases. We are currently observing the repurposing of immuno-oncology drugs and…

July 6, 2020 - 7 minutesmins - By Maya Chergova

News and Trends 29 Sep 2016

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

…to be critical about the immuno-oncology hype. Immuno-oncology has become all the rage lately, and the hype has led to some major investments, acquisitions, deals and partnerships. It seems that…

September 29, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

…not having a patient enrolled for six months, which would be terrible as patients would not have access to new therapeutics.” Future ADC outlook in oncology As oncology moves toward…

November 26, 2024 - 8 minutesmins - By Will Chu

News and Trends 5 Dec 2016

Video: Chatting with Immunocore about the Potential of Immuno-oncology

…To close our second edition of Refresh, I discussed the field of immuno-oncology and Immunocore‘s position in it with the company’s CBO, Eva-Lotta Allan. The day before, immuno-oncology suffered another…

December 5, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 3 Jun 2020

What Did European Oncology Players Offer at ASCO 2020?

Despite widespread clinical trial delays caused by the coronavirus pandemic, many oncology biotechs have been able to continue their fight against cancer. With advances in CAR T-cell therapies, cancer vaccines,…

June 3, 2020 - 10 minutesmins - By Jonathan Smith

ASCO 2024: advances in oncology clinical trials

In Depth 10 Jun 2024

ASCO 2024: The latest advances in oncology clinical trials

This month kicked off with one of the leading cancer summits in the U.S., where experts gather to present novel, promising cancer research at the American Society of Clinical Oncology…

June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter

Catherine Pickering iOnctura e1575382680993

Interview 22 Jul 2019

Turning Shelved Drugs into a New Promise for Immuno-Oncology

…and working in business development at the biotech company Antisoma, she was recruited by Merck. Pickering was heading Merck’s business development oncology team during the immuno-oncology boom. At the time,…

July 22, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

In Depth 26 Sep 2024

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Radiopharmaceuticals are a rapidly evolving class of drugs that combine radioactive isotopes with biological molecules to target and treat specific diseases, most notably in oncology and neurology. These agents have…

September 26, 2024 - 14 minutesmins - By Jules Adam

Ryvu Therapeutics bags €22M from EIB to work on new cancer treatments

News and Trends 1 Aug 2022

Ipsen and Marengo Therapeutics partner to push immuno-oncology candidates into the clinic

…Marengo’s R&D expertise of a novel mechanism of T cell activation with Ipsen’s global oncology footprint for clinical development and commercialization. Under the terms of the agreement, Ipsen will make…

August 1, 2022 - 4 minutesmins - By Jim Cornall

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: oncology

Immuno-Oncology: From Science Fiction to the Mainstream

Alkermes to separate oncology business

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

How Immuno-Oncology Contributes to the Fight Against Covid-19

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

Video: Chatting with Immunocore about the Potential of Immuno-oncology

What Did European Oncology Players Offer at ASCO 2020?

ASCO 2024: The latest advances in oncology clinical trials

Turning Shelved Drugs into a New Promise for Immuno-Oncology

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Ipsen and Marengo Therapeutics partner to push immuno-oncology candidates into the clinic

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!